Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study
European Journal of Public Health · 2024
DOI: 10.1093/eurpub/ckae038 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Public Health, 2024. Verfasst von Francisco Estupiñán-Romero und 17 weiteren Autor:innen. Beteiligte Einrichtung: Data Science for Health Services and Policy Research, Health Science Institute in Aragon (IACS), Aragon, Spain. Hauptthemen laut MEDLINE: COVID-19, Breast Neoplasms, SARS-CoV-2, Time-to-Treatment. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation programme, European Union’s Horizon 2020 research and innovation programme.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The indirect impact of the coronavirus disease 2019 pandemic on healthcare services was studied by assessing changes in the trend of the time to first treatment for women 18 or older who were diagnosed and treated for breast cancer between 2017 and 2021.
Methods
An observational retrospective longitudinal study based on aggregated data from four European Union (EU) countries/regions investigating the time it took to receive breast cancer treatment. We compiled outputs from a federated analysis to detect structural breakpoints, confirming the empirical breakpoints by differences between the trends observed and forecasted after March 2020. Finally, we built several segmented regressions to explore the association of contextual factors with the observed changes in treatment delays.
Results
We observed empirical structural breakpoints on the monthly median time to surgery trend in Aragon (ranging from 9.20 to 17.38 days), Marche (from 37.17 to 42.04 days) and Wales (from 28.67 to 35.08 days). On the contrary, no empirical structural breakpoints were observed in Belgium (ranging from 21.25 to 23.95 days) after the pandemic's beginning. Furthermore, we confirmed statistically significant differences between the observed trend and the forecasts for Aragon and Wales. Finally, we found the interaction between the region and the pandemic's start (before/after March 2020) significantly associated with the trend of delayed breast cancer treatment at the population level.
Conclusions
Although they were not clinically relevant, only Aragon and Wales showed significant differences with expected delays after March 2020. However, experiences differed between countries/regions, pointing to structural factors other than the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Data Science for Health Services and Policy Research, Health Science Institute in Aragon (IACS), Aragon, Spain.
- Sciensano, Brussels, Belgium.
- Belgian Cancer Registry, Brussels, Belgium.
- Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University (SU), Swansea, United Kingdom.
- Center of Epidemiology Biostatistics and Medical Information Technology, Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche Home, Marche, Italy.
- Department of Cardiovascular and Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Italy.
ORCID-Profile: Francisco Estupiñán-Romero, Natalia Martínez-Lizaga, Petronille Bogaert, Nienke Schutte, Andrea Faragalli, Luigi Palmieri, Martin Thiβen, Enrique Bernal-Delgado
Förderung
- European Union's Horizon 2020 research and innovation programme
- European Union’s Horizon 2020 research and innovation programme
Zitieren
APA
Estupiñán-Romero, F., Royo-Sierra, S., González-Galindo, J., Martínez-Lizaga, N., Bogaert, P., Schutte, N., Van Eycken, L., Van Damme, N., Henau, K., Lyons, R. A., Aldridge, S. J., Faragalli, A., Carle, F., Gesuita, R., Palmieri, L., Misiņš, J., Thiβen, M., & Bernal-Delgado, E. (2024). Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckae038
Vancouver
Estupiñán-Romero F, Royo-Sierra S, González-Galindo J, Martínez-Lizaga N, Bogaert P, Schutte N, et al. Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study. European Journal of Public Health. 2024. doi:10.1093/eurpub/ckae038
BibTeX
@article{EstupinRomero2024,
author = {Estupiñán-Romero, Francisco and Royo-Sierra, Santiago and González-Galindo, Javier and Martínez-Lizaga, Natalia and Bogaert, Petronille and Schutte, Nienke and Van Eycken, Liesbet and Van Damme, Nancy and Henau, Kris and Lyons, Ronan A and Aldridge, Sarah J and Faragalli, Andrea and Carle, Flavia and Gesuita, Rosaria and Palmieri, Luigi and Misiņš, Jānis and Thiβen, Martin and Bernal-Delgado, Enrique},
title = {Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study},
journal = {European Journal of Public Health},
year = {2024},
doi = {10.1093/eurpub/ckae038}
}
EUVIMED